MGY-1838

N/A

Report date: 2025/01/26 16:09:17

Base Information

Drug NameMGY-1838
Drug Alias Nameregulatory T cell therapy (Immunis Bio)MGY-1838
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionRegulatory T-lymphocytes modulatorsImmunostimulants
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesPsoriasisLupus Erythematosus, Systemic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImunis Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImunis Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesPsoriasisLupus Erythematosus, Systemic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A